Legal Representation
Attorney
Margaret M. Serrano, Esq.
USPTO Deadlines
Application History
23 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 26, 2007 | MAB3 | O | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
Mar 23, 2007 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
Mar 23, 2007 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
Nov 14, 2006 | CNCF | S | ACTION CONTINUING FINAL - COMPLETED | Loading... |
Nov 14, 2006 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
Sep 28, 2006 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
Sep 28, 2006 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Sep 28, 2006 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
Sep 27, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 27, 2006 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Mar 27, 2006 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Mar 10, 2006 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Mar 8, 2006 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Mar 8, 2006 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Sep 7, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Sep 7, 2005 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
Aug 26, 2005 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Aug 22, 2005 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Aug 22, 2005 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Feb 21, 2005 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Feb 21, 2005 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Feb 21, 2005 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Oct 26, 2004 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical and medicinal products and substances for human use, namely, pharmaceutical and medicinal preparations for the prevention and/or treatment of arthritis; nutritional disorders; autoimmune diseases; disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculoskeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, in oncology, and in ophthalmology; for use in the gastroenterological area; for the prevention and treatment of ocular disorders or diseases; and antibacterials, antivirals, antibiotics, and antifungals for the treatment of viral and bacterial infections
First Use Anywhere:
0
First Use in Commerce:
0
Class 039
Transport by truck, train, ferry, boat, rail, or air, and warehousing services, namely, distribution and storage of drugs, pharmaceutical and medicinal products
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific research and analysis services for further application in the medical and pharmaceutical fields
First Use Anywhere:
0
First Use in Commerce:
0
Class 044
Pharmacy advisory services and consulting services in the fields of pharmaceutical and medicinal products and substances for human use
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
039
042
044